Eric A. Collisson - Concepedia

Author

Eric A. Collisson

University of California, San Francisco ORCID

Also Known As

Aatur Singhi, Berrios, David I, E A Collisson, E. A. Collisson, E. Collisson, E.A. Collisson, Eric A Collisson, Eric A. Collisson, Eric Andrew Collisson, Eric Collisson

353

Publications

15.6K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco UCSF Helen Diller Family Comprehensive Cancer Center Oregon Health & Science University University of California, Los Angeles The University of Texas MD Anderson Cancer Center

About

Eric A. Collisson is an author at University of California, San Francisco specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	8.9K
2	Engineering	2	2	84
3	Health Sciences	2	2	27
4	Natural Sciences	2	2	29
5	Public Health	1	1	16

Eric A. Collisson

Publications

15.1K

Citations

H-Index

Page 1

	Year	Citations
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma Benjamin J. Raphael, Ralph H. Hruban, Andrew J. Aguirre, Cancer Cell Functional GenomicsPancreatic CancerPathologyCancer GenomicsPancreatic Ductal Adenocarcinoma	2017	2K
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy Eric A. Collisson, Anguraj Sadanandam, Peter Olson, Nature Medicine Pancreatic CancerMedicinePathologyPancreatic SurgeryPancreatic Ductal Adenocarcinoma	2011	1.9K
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy Mara H. Sherman, Ruth T. Yu, Dannielle D. Engle, Cell Tumor BiologyPancreatic CancerMedicinePharmacologyGastroenterology	2014	1.1K
A colorectal cancer classification system that associates cellular phenotype and responses to therapy Anguraj Sadanandam, Costas A. Lyssiotis, Krisztián Homicskó, Nature Medicine Tumor BiologyOncologyTumor HeterogeneityMedicineColorectal Cancer	2013	954
Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig, Cancer Discovery	2015	782
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA Richard B. Lanman, Stefanie Mortimer, Oliver A. Zill, PLoS ONE	2015	708
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression Hanane Laklai, Yekaterina A. Miroshnikova, Michael W. Pickup, Nature Medicine FibrosisPancreatic CancerTumor ProgressionPathologyCancer Genomics	2016	583
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Luping Lin, Amit J. Sabnis, Elton Chan, Nature Genetics MedicineMek-targeted Cancer TherapiesHippo Effector YapCancer BiologyCell Biology	2015	548
Subtype and pathway specific responses to anticancer compounds in breast cancer Laura M. Heiser, Anguraj Sadanandam, Wen‐Lin Kuo, Proceedings of the National Academy of Sciences Drug TargetBreast OncologyChemoprevention StrategyTherapeutic CompoundsCancer Biology	2011	501
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma Nicholas J. Wang, Zachary Sanborn, Kelly L. Arnett, Proceedings of the National Academy of Sciences	2011	463

Page 1